title: More than a REASON to use arterial stiffness as risk marker and therapeutic target in hypertension.
authors.affiliation: Clinical Research Unit, Preventive Cardiology, Hospital S.M. della Misericordia, Perugia, Italy. fangeli@cardionet.it
authors.forename: Fabio
authors.initials: F
authors.lastname: Angeli
authors.forename: Gianpaolo
authors.initials: G
authors.lastname: Reboldi
authors.forename: Paolo
authors.initials: P
authors.lastname: Verdecchia
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D001011:Aorta / Q000503:physiopathology*; D001262:Atenolol / Q000627:therapeutic use; D001783:Blood Flow Velocity / Q000502:physiology; D001794:Blood Pressure / Q000502:physiology; D001916:Brachial Artery / Q000503:physiopathology*; D002318:Cardiovascular Diseases / Q000453:epidemiology*; D004359:Drug Therapy, Combination; D004548:Elasticity / Q000502:physiology*; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology*; D007190:Indapamide / Q000627:therapeutic use; D020913:Perindopril / Q000627:therapeutic use; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents; D001262:Atenolol; D007190:Indapamide; D020913:Perindopril